HANSEN Pharma Hits 5‑Day Record‑High Rally, Surges to 52‑Week Peak
HANSEN Pharmaceutical hits 5‑day record‑high trading, topping 52‑week high and fueling investor confidence in its TCM innovation pipeline.
2 minutes to read
HANSEN
Hansen Pharma’s 50%+ Profit Surge Fuels Mid-Cap Innovation-Drug Rally in China
HANSEN Pharma surges as China’s innovation‑drug boom fuels a 50%+ earnings jump and a 2‑day limit‑up streak, spotlighting strong growth prospects.
4 minutes to read
HANSEN Pharmaceutical Soars to Limit‑Up on April 28, 2026 Amid Shenzhen’s Market Dip
HANSEN 002412’s limit‑up on April 28 reflects its robust, diversified drug portfolio and sector resilience, offering attractive upside amid a correcting market.
3 minutes to read